• 1. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275
• 2. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 3. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 4. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 5. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812

Professional Introduction to 1-Benzyl-3-iodo-1H-pyrazole (CAS No. 1026893-32-2)

1-Benzyl-3-iodo-1H-pyrazole is a significant compound in the field of pharmaceutical chemistry, characterized by its unique structural and chemical properties. This heterocyclic compound, with the CAS number 1026893-32-2, has garnered considerable attention due to its potential applications in drug discovery and medicinal chemistry. The presence of both benzyl and iodo substituents on the pyrazole ring imparts distinct reactivity, making it a valuable intermediate in synthesizing various bioactive molecules.

The< strong>benzyl group in 1-Benzyl-3-iodo-1H-pyrazole contributes to the compound's solubility and stability, while the< strong>iodo substituent enhances its reactivity in cross-coupling reactions. These characteristics have made it a popular choice for researchers exploring novel synthetic pathways and molecular architectures. Recent advancements in pharmaceutical chemistry have highlighted the utility of this compound in developing small-molecule inhibitors and therapeutic agents.

In the realm of medicinal chemistry, 1-Benzyl-3-iodo-1H-pyrazole has been investigated for its role in synthesizing kinase inhibitors, which are crucial in treating various diseases, including cancer and inflammatory disorders. The pyrazole core is a well-documented pharmacophore, known for its ability to modulate enzyme activity. By incorporating the< strong>benzyl and< strong>iodo groups, researchers can fine-tune the electronic and steric properties of the molecule, leading to enhanced binding affinity and selectivity.

Recent studies have demonstrated the effectiveness of 1-Benzyl-3-iodo-1H-pyrazole in generating novel pyrazole derivatives with potent biological activities. For instance, modifications of this scaffold have yielded compounds with significant anti-inflammatory and anti-proliferative effects. The< strong>iodo moiety, in particular, has been leveraged in palladium-catalyzed cross-coupling reactions, enabling the construction of complex molecular frameworks with high precision.

The synthesis of 1-Benzyl-3-iodo-1H-pyrazole typically involves multi-step organic transformations, starting from readily available precursors. The introduction of the< strong>benzyl group often requires benzyl halides or boronic acids, while the< strong>iodo substituent can be incorporated through halogenation reactions. These synthetic strategies highlight the compound's versatility and ease of functionalization, making it an attractive candidate for further exploration.

The growing interest in heterocyclic compounds like 1-Benzyl-3-iodo-1H-pyrazole is driven by their diverse biological activities and synthetic utility. Researchers are continuously discovering new ways to exploit the< strong>benzyl-substituted pyrazoles for drug development. For example, recent work has focused on using this compound as a building block for designing molecules that interact with specific protein targets, thereby modulating cellular processes.

In conclusion, 1-Benzyl-3-iodo-1H-pyrazole (CAS No. 1026893-32-2) represents a promising compound in pharmaceutical research. Its unique structural features and reactivity make it a valuable tool for synthesizing bioactive molecules with potential therapeutic applications. As our understanding of medicinal chemistry evolves, compounds like this will continue to play a crucial role in the development of novel treatments for various diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)